Santa Casa de Porto Alegre Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00947323
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Santa Casa de Porto Alegre